(19)

(11)

EP 4 798 695 A1

(12)

(43) Date of publication: 02.09.2026 Bulletin 2026/36 (21) Application number: 24805107.0 (22) Date of filing: 25.10.2024

(51) International Patent Classification (IPC):  C12N 1/18(2026.01) C12P 7/10(2006.01) C12N 1/22(2006.01) C12R 1/865(2006.01) (52) Cooperative Patent Classification (CPC): C12P 2203/00; C12N 1/185; C12R 2001/865; C12N 1/22; C12P 7/10; Y02E 50/10 (86) International application number: PCT/EP2024/080289 (87) International publication number: WO 2025/088155 (01.05.2025 Gazette 2025/18)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 25.10.2023 US 202363593006 P (71) Applicants: Novozymes A/S 2880 Bagsvaerd (DK) Microbiogen Pty. Ltd. Sydney, New South Wales 2113 (AU)	(72) Inventors: BELL, Philip, John, Livingstone Sydney, New South Wales 2113 (AU) BORGES DA SILVA, Eduardo, Alberto 83707-660 Paraná (PR) (BR) ARCENAL, Psyche Sydney, New South Wales 2113 (AU) (74) Representative: NVS EPO Representatives  Krogshoejvej 36 2880 Bagsvaerd 2880 Bagsvaerd (DK)